X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
humans (17) 17
animals (13) 13
male (10) 10
oncology (10) 10
cancer (9) 9
dosimetry (9) 9
mice (9) 9
female (7) 7
nuclear medicine (7) 7
pet (7) 7
aged (6) 6
middle aged (6) 6
positron-emission tomography (6) 6
radioimmunotherapy (6) 6
radiology, nuclear medicine & medical imaging (6) 6
tissue distribution (6) 6
tumor cells, cultured (6) 6
article (5) 5
autoradiography (5) 5
colorectal cancer (5) 5
iodine radioisotopes (5) 5
medical imaging (5) 5
neoplasm metastasis (5) 5
positron-emission-tomography (5) 5
tomography (5) 5
tumors (5) 5
a33 (4) 4
bioverteilung (4) 4
gangliosides (4) 4
medicine & public health (4) 4
metastases (4) 4
metastasis (4) 4
monoclonal-antibody (4) 4
patients (4) 4
positron emission (4) 4
positron emission tomography (4) 4
prostate cancer (4) 4
radiation therapy (4) 4
adult (3) 3
analysis (3) 3
antibodies, monoclonal (3) 3
antibodies, monoclonal, humanized - pharmacokinetics (3) 3
antibody (3) 3
antigen (3) 3
antikörper (3) 3
breast cancer (3) 3
cardiology (3) 3
care and treatment (3) 3
cell hypoxia (3) 3
colon (3) 3
colorectal neoplasms - diagnostic imaging (3) 3
colorectal neoplasms - immunology (3) 3
colorectal neoplasms - pathology (3) 3
computed tomography (3) 3
expression (3) 3
heart (3) 3
her2 (3) 3
i-124 (3) 3
imaging / radiology (3) 3
immunohistochemistry (3) 3
in-vivo-untersuchung (3) 3
iodine-124 (3) 3
lesions (3) 3
liver (3) 3
melanoma (3) 3
mice, nude (3) 3
modeling (3) 3
neoplasm transplantation (3) 3
organs (3) 3
orthopedics (3) 3
pet imaging (3) 3
pharmacology (3) 3
pharmacology & pharmacy (3) 3
positron-emission tomography - methods (3) 3
prostatic neoplasms - pathology (3) 3
radiation dosage (3) 3
radiobiology (3) 3
radiopharmaceuticals - pharmacokinetics (3) 3
radiopharmaka (3) 3
sensitivity and specificity (3) 3
tomography, emission-computed - methods (3) 3
tumor (3) 3
tumor hypoxia (3) 3
zirconium isotopes (3) 3
124i (2) 2
89zr (2) 2
89zr-pertuzumab (2) 2
antibodies (2) 2
antigens (2) 2
biochemistry & molecular biology (2) 2
biosynthesis (2) 2
breast-cancer (2) 2
carcinoma (2) 2
correlative study (2) 2
deferoxamine (2) 2
dosimeters (2) 2
dosimetrie (2) 2
epidermal growth factor (2) 2
erbb-2 protein (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, ISSN 0161-5505, 06/2018, Volume 59, Issue 6, pp. 900 - 906
In what we believe to be a first-in-human study, we evaluated the safety and dosimetry of 89Zr-pertuzumab PET/CT for human epidermal growth factor receptor 2... 
Index Medicus | CT | radiobiology | dosimetry | 89Zr-pertuzumab | Oncology | breast cancer | PET
Journal Article
Nature Biotechnology, ISSN 1087-0156, 04/2003, Volume 21, Issue 4, pp. 405 - 413
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2017, Volume 79, Issue 2, pp. 421 - 429
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2014, Volume 41, Issue 11, pp. 2093 - 2105
Given the bone tropism of prostate cancer, conventional imaging modalities poorly identify or quantify metastatic disease. 89Zr-huJ591 positron emission... 
Medicine & Public Health | Orthopedics | J591 antibody | Radioimmunotherapy | 89 Zr-huJ591 | Oncology | Nuclear Medicine | Dosimetry | Imaging / Radiology | Cardiology | Prostate cancer | Zr-huJ591 | Liver cancer | Care and treatment | Metastasis | PET imaging | Immunotherapy | 89Zr-huJ591
Journal Article
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 05/2019, p. jnumed.118.222844
Six-transmembrane epithelial antigen of prostate-1 (STEAP1) is a relatively new identified target in prostate cancer. We evaluated the ability of PET/CT with... 
Journal Article
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2017, Volume 58, p. 837
Objectives: CA19-9 (also known as sialyl Lewis A) is widely expressed on tumors of the gastrointestinal tract and has been used clinically as a tumor marker.... 
Heart | Nuclear medicine | Renal function | Zirconium isotopes | Liver | Lung | Immunoglobulin G | Radiation | Blood | Metastases | Computed tomography | Tomography | Bone marrow | Spleen | Excretion | Kidneys | Medical imaging | Tumor markers | Digestive system | Organs | Positron emission | Ilium | Gastrointestinal tract | Patients | Low level | Estimates | Radiation dosage | Pancreatic cancer | Bone | Tumors | Cancer
Journal Article
Journal Article
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 12/2016, Volume 57, Issue 12, p. 1858
  We conducted a phase I dose-escalation study with ^sup 89^Zr-desferrioxamine-IAB2M (^sup 89^Zr-IAB2M), an anti-prostate-specific membrane antigen minibody,... 
Antigens | Nuclear medicine | Pharmacology | Dosimetry | Metastasis | Radiation therapy | Prostate cancer
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 12/2016, Volume 57, Issue 12, pp. 1858 - 1858
We conducted a phase I dose-escalation study with super( 89)Zr-desferrioxamine-IAB2M ( super( 89)Zr-IAB2M), an anti-prostate-specific membrane antigen... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.